Our Team of Experts
Team Leadership
Abdel A. Fawzy, PhD
Managing Partner
Prior to co-founding Asterix Pharma Consulting, Abdel was EVP Pharmaceutical Development and Founder at Matinas BioPharma, both an omega-3 company and a nanotechnology pharmaceutical delivery company with a focus in the anti-infective field. Earlier he was a Managing Partner and Founder of DeMelle Pharmaceutical Consulting, a specialty CMC focused consulting firm, and Executive Director and head of the Pharmaceutical Development group at Reliant Pharmaceuticals, Inc., a cardiovascular and dyslipidemia company. Prior to Reliant, Abdel held pharmaceutical development positions at Ascent Pharmaceuticals, DuPont, and Squibb Marsam Pharmaceuticals. He is an inventor on numerous published patents and patent applications in the pharmaceutical field. Abdel completed a postdoctoral fellowship in Biochemistry at Medical College of Virginia in Richmond, Va. Abdel received his Ph.D. in Pharmaceutical Technology from Tuebingen University in Germany, a Pharmacy degree from Temple University in Philadelphia, PA, and an MS in Pharmaceutical Technology from the Cairo School of Pharmacy in Egypt.
George Bobotas, PhD
Managing Partner
Prior to co-founding Asterix Pharma Consulting, George was CSO and Founder at Matinas BioPharma, both an omega-3 company and a nanotechnology pharmaceutical delivery company with a focus in the anti-infective field. Earlier he was a Managing Partner and Founder of DeMelle Pharmaceutical Consulting, a specialty CMC focused consulting firm, and Vice President Scientific Affairs at Reliant Pharmaceuticals, Inc., a cardiovascular and dyslipidemia company. Prior to Reliant, George was the founder and Executive Director of the Covance Center for CNS Research. Earlier in his career, George held senior positions at Somerset Pharmaceuticals, Mylan Laboratories, and Forest Laboratories. He is an inventor on numerous published patents and patent in the pharmaceutical field. George received his Ph.D. in Biochemistry from the City University of New York, an M.A. in Physical Chemistry from Smith College, Northhampton, Massachusetts, and a B.A. in Chemistry from Windham College, Vermont.
Roelof Rongen, MScEng, MBA
Managing Partner
Prior to co-founding Asterix Pharma Consulting, Roelof was the CEO and Founder of Matinas BioPharma, both an omega-3 company and a nanotechnology pharmaceutical delivery company with a focus in the anti-infective field. Earlier he was the Founder and Chairman of Essential Fatty Acid Therapeutics LLC, a biotech company focused on the development of innovative fatty acid derivatives, Executive Vice President North American Operations for Trygg Pharma AS, an omega-3 development company, and Vice President of Life Cycle Management and Intellectual Property at Reliant Pharmaceuticals, Inc., a cardiovascular and dyslipidemia company. While at Reliant, Roelof held various earlier positions, including head of the Omacor®/Lovaza® launch team, Executive Director of Marketing for Lescol® and Executive Director of Business Development. Prior to Reliant, Roelof was Global Product Director for Humira® at BASF Pharma; Consultant at The Wilkerson Group in New York, Consultant at Arthur D. Little in Amsterdam, and a Research Fellow in biochemistry at Baylor University in Texas. Roelof earned an MBA from Kellogg GSM at Northwestern University in Evanston, IL, and a graduate engineering degree in Molecular Sciences from Wageningen University in the Netherlands.